We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
117 hedge funds and large institutions have $1.01B invested in Atara Biotherapeutics in 2019 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 45 increasing their positions, 29 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
55% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 29
33% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 15
21% more capital invested
Capital invested by funds: $833M → $1.01B (+$174M)
4% more funds holding
Funds holding: 112 → 117 (+5)
0.12% more ownership
Funds ownership: 4.39% → 4.52% (+0.12%)
43% less call options, than puts
Call options by funds: $1.22M | Put options by funds: $2.13M
Holders
117
Holders Change
+5
Holders Change %
+4.46%
% of All Funds
2.31%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
20
Increased
45
Reduced
29
Closed
15
Calls
$1.22M
Puts
$2.13M
Net Calls
-$909K
Net Calls Change
-$2.5M
Top Buyers
Top Sellers
| 1 |
Neuberger Berman Group
New York
|
-$13.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.6M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$5.93M |
| 4 |
State Street
Boston,
Massachusetts
|
-$5.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$5.34M |
